Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma

Cancer Cell

Volumn 4, Issue 5, 2003, Pages 383-391

  Hoffman, Jason A ^a,c   Giraudo, Enrico ^b   Singh, Mallika ^b,d   Zhang, Lianglin ^a   Inoue, Masahiro ^b,e   Porkka, Kimmo ^a   Hanahan, Douglas ^b   Ruoslahti, Erkki ^a  

^a BURNHAM INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d EXELIXIS INC   (United States)

^e OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINYLASPARTYLTHREONINE; CYSTEINYLGLYCYLLYSYLARGINYLLYSINE; CYSTEINYLSERYLARGINYLPROLYLARGINYLARGINYLSERYLGLUTAMYLCYSTEINE; HEPARAN SULFATE; KALLIKREIN; KALLIKREIN INHIBITOR; PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CANCER STAGING; CONTROLLED STUDY; DYSPLASIA; EXPERIMENTAL MODEL; MOUSE; NONHUMAN; PANCREAS ISLET CELL CARCINOMA; PHAGE DISPLAY; PRECANCER; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; TRANSGENIC MOUSE; TUMOR VASCULARIZATION;

ANIMALIA; MUS MUSCULUS;

EID: 0344309914     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(03)00273-3     Document Type: Article

References (47)

1. Arap W., Pasqualini R., Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science. 279:1998;377-380.
2. Arbeit J., Munger K., Howley P., Hanahan D. Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice. J. Virol. 68:1994;4358-4368.
3. Arbeit J., Olson D., Hanahan D. Upregulation of fibroblast growth factors and their receptors during multi-stage epidermal carcinogenesis in K14-HPV16 transgenic mice. Oncogene. 13:1996;1847-1857.
4. Bergers G., Javaherian K., Lo K., Folkman J., Hanahan D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science. 284:1999;808-812.
5. Bergers G., Song S., Meyer-Morse N., Bergsland E., Hanahan D. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J. Clin. Invest. 111:2003;1287-1295.
6. Bregman M., Meyskens F.J. Difluoromethylornithine enhances inhibition of melanoma cell growth in soft agar by dexamethasone, clone A interferon and retinoic acid. Int. J. Cancer. 37:1986;101-107.
7. Burg M., Pasqualini R., Arap W., Ruoslahti E., Stallcup W. NG2 proteoglycan-binding peptides target tumor neovasculature. Cancer Res. 59:1999;2869-2874.
8. Carmeliet P., Jain R. Angiogenesis in cancer and other diseases. Nature. 407:2000;249-257.
9. Carmeliet P., Ng Y.S., Nuyens D., Theilmeier G., Brusselmans K., Cornelissen I., Ehler E., Kakkar V.V., Stalmans I., Mattot V., et al. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat. Med. 5:1999;495-502.
10. Chang Y.S., di Tomaso E., McDonald D.M., Jones R., Jain R.K., Munn L.L. Mosaic blood vessels in tumors. Frequency of cancer cells in contact with flowing blood Proc. Natl. Acad. Sci. USA. 97:2000;14608-14613.
11. Coussens L., Hanahan D., Arbeit J. Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice. Am. J. Pathol. 149:1996;1899-1917.
12. Coussens L., Raymond W., Bergers G., Laig-Webster M., Behrendtsen O., Werb Z., Caughey G., Hanahan D. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 13:1999;1382-1397.
13. Coussens L., Tinkle C., Hanahan D., Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell. 103:2000;481-490.
14. Craggs G., Kellie S. A functional nuclear localization sequence in the C-terminal domain of SHP-1. J. Biol. Chem. 276:2001;23719-23725.
15. Diamandis E., Yousef G., Luo L., Magklara A., Obiezu C. The new human kallikrein gene family. implications in carcinogenesis Trends Endocrinol. Metab. 11:2000;54-60.
16. El-Sheikh A., Liu C., Huang H., Edgington T.S. A novel vascular endothelial growth factor heparin-binding domain substructure binds to glycosaminoglycans in vivo and localizes to tumor microvascular endothelium. Cancer Res. 62:2002;7118-7123.
17. Fadok V., Bratton D., Rose D., Pearson A., Ezekewitz R., Henson P. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature. 405:2000;85-90.
18. Gee M.S., Procopio W.N., Makonnen S., Feldman M.D., Yeilding N.M., Lee W.M.F. Tumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapy. Am. J. Pathol. 162:2003;183-193.
19. Gomis-Ruth F.X., Bayes A., Sotiropoulou G., Pampalakis G., Tsetsenis T., Villegas V., Aviles F.X., Coll M. The structure of human prokallikrein 6 reveals a novel activation mechanism for the kallikrein family. J. Biol. Chem. 277:2002;27273-27281.
20. Guy C., Cardiff R., Muller W. Induction of mammary tumors by expression of polyomavirus middle T oncogene. a transgenic mouse model for metastatic disease Mol. Cell. Biol. 12:1992;954-961.
21. Hanahan D. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature. 315:1985;115-122.
22. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86:1996;353-364.
23. Hanahan D., Weinberg R. The hallmarks of cancer. Cell. 100:2000;57-70.
24. Heidtmann H., Nettelbeck D., Mingels A., Jager R., Welker H., Kontermann R. Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen. Br. J. Cancer. 81:1999;1269-1273.
25. Hoffman, J., Laakkonen, P., Porkka, K., Bernasconi, M., and Ruoslahti, E. (2004). In vivo and ex vivo selections using phage-displayed libraries. In Phage Display: A Practical Approach, in press.
26. Jia H., Jezequel S., Lohr M., Shaikh S., Davis D., Soker S., Selwood D., Zachary I. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF. Biochem. Biophys. Res. Commun. 283:2001;164-173.
27. Jonca F., Ortega N., Gleizes P.-E., Bertr N., Plouet J. Cell release of bioactive fibroblast growth factor 2 by exon 6-encoded sequence of vascular endothelial growth factor. J. Biol. Chem. 272:1997;24203-24209.
28. Joyce J.A., Laakkonen P., Bernasconi M., Bergers G., Ruoslahti E., Hanahan D. Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis. Cancer Cell. 4:2003;393-403. this issue.
29. Kawai J., Shinagawa A., Shibata K., Yoshino M., Itoh M., Ishii Y., Arakawa T., Hara A., Fukunishi Y., Konno H., et al. Functional annotation of a full-length mouse cDNA collection. Nature. 409:2001;685-690.
30. Laakkonen P., Porkka K., Hoffman J., Ruoslahti E. A tumor-homing peptide with a targeting specificity related to lymphatic vessels. Nat. Med. 8:2002;751-755.
31. LeCouter J., Lin R., Tejada M., Frantz G., Peale F., Kenneth J.H., Ferrara N. The endocrine-gland-derived VEGF homologue Bv8 promotes angiogenesis in the testis. Localization of Bv8 receptors to endothelial cells Proc. Natl. Acad. Sci. USA. 100:2003;2685-2690.
32. Miao R.Q., Agata J., Chao L., Chao J. Kallistatin is a new inhibitor of angiogenesis and tumor growth. Blood. 100:2002;3245-3252.
33. Pasqualini R., Arap W., McDonald D. Probing the structural and molecular diversity of tumor vasculature. Trends Mol. Med. 8:2002;563-571.
34. Porkka K., Laakkonen P., Hoffman J., Bernasconi M., Ruoslahti E. A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo. Proc. Natl. Acad. Sci. USA. 99:2002;7444-7449.
35. Price J., Polyzos A., Zhang R., Daniels L. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res. 50:1990;717-721.
36. Qiao D., Meyer K., Mundhenke C., Drew S.A., Friedl A. Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 signaling in brain endothelial cells. Specific role for glypican-. 1(in glioma angiogenesis. J. Biol. Chem. 278):2003;16045-16053.
37. Ran S., Downes A., Thorpe P.E. Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer Res. 62:2002;6132-6140.
38. Roberts W., Delaat J., Nagane M., Huang S., Cavenee W., Palade G. Host microvasculature influence on tumor vascular morphology and endothelial gene expression. Am. J. Pathol. 153:1998;1239-1248.
39. Roghani M., Moscatelli D. Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms. J. Biol. Chem. 267:1992;22156-22162.
40. Ruoslahti E. Specialization of tumour vasculature. Nat. Rev. Cancer. 2:2002;83-90.
41. Smetsers T.F., van de Westerlo E.M., ten Dam G.B., Clarijs R., Versteeg E.M., van Geloof W.L., Veerkamp J.H., van Muijen G.N., van Kuppevelt T.H. Localization and characterization of melanoma-associated glycosaminoglycans. differential expression of chondroitin and heparan sulfate epitopes in melanoma Cancer Res. 63:2003;2965-2970.
42. Smith-McCune K., Zhu Y.H., Hanahan D., Arbeit J. Cross-species comparison of angiogenesis during the premalignant stages of squamous carcinogenesis in the human cervix and K14-HPV16 transgenic mice. Cancer Res. 57:1997;1294-1300.
43. Thurston G., McLean J., Rizen M., Baluk P., Haskell A., Murphy T., Hanahan D., McDonald D. Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice. J. Clin. Invest. 101:1998;1401-1413.
44. Yayama K., Kunimatsu N., Teranishi Y., Takano M., Okamoto H. Tissue kallikrein is synthesized and secreted by human vascular endothelial cells. Biochim. Biophys. Acta. 1593:2003;231-238.
45. Yousef G., Diamandis E. The expanded human kallikrein gene family. locus characterization and molecular cloning of a new member, KLK-L3 (KLK9) Genomics. 65:2000;184-194.
46. Yousef G.M., Kyriakopoulou L.G., Scorilas A., Fracchioli S., Ghiringhello B., Zarghooni M., Chang A., Diamandis M., Giardina G., Hartwick W.J., et al. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer. A new independent and favorable prognostic marker Cancer Res. 61:2001;7811-7818.
47. Zhou J., Doorbar J., Sun X., Crawford L., McLean C., Frazer I. Identification of the nuclear localization signal of human papillomavirus type 16 L1 protein. Virology. 185:1991;625-632.